Results 171 to 180 of about 95,577 (390)
Movement Disorders Clinical Practice, EarlyView.Abstract Background Non‐motor fluctuations, characterized by variability in mood and cognition, are prevalent in advanced Parkinson's disease (PD), but less is known about these fluctuations in early PD. Objective The objective was to characterize fluctuations in cognition and mood in early PD without cognitive impairment.
Abhimanyu Mahajan +4 more
wiley +1 more source
Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism. [PDF]
, 1976 D L McLellan
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister +11 more
wiley +1 more source
Myoclonic Dystonia: A Common Phenomenology in the Pleomorphic Movements of Angelman Syndrome
Movement Disorders Clinical Practice, EarlyView.Abstract Background Angelman syndrome (AS) is a neurodevelopmental disorder characterized by developmental delay, intellectual disability, a sociable demeanor, and abnormal movements. People with AS often exhibit multiple types of abnormal movements, including nonepileptic myoclonus, tremor, and dystonia, which hamper attempts to identify phenomenology
Robert P. Carson +8 more
wiley +1 more source
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
, 1975 Daniel Tarsy +2 more
openalex +1 more source
Running into Trouble: The Problem of Overexercise in Parkinson's Disease (in some)
Movement Disorders Clinical Practice, EarlyView.
Lennard I. Boon +2 more
wiley +1 more source